Incyte – Sponsored Industry Symposium

We are delighted to invite you to Incyte’s educational satellite symposium
‘Personalised Approaches in Cholangiocarcinoma’

Friday 11th September, 18:20 CET

Join our esteemed faculty as they discuss how cholangiocarcinoma represents a molecularly diverse subgroup of biliary tract cancers and explore the future direction of precision medicine.

Chair: Prof Bruno Sangro

Dr Harpreet Wasan
(United Kingdom)

Dr Ana Vivancos

Dr Joachim Mertens

There have been relatively limited improvements in treatment outcomes and survival for patients with cholangiocarcinoma during the past decade.1 There is a clear need for novel therapeutic approaches and optimised clinical management, especially for the large proportion of patients who are diagnosed with advanced disease.2 The introduction of next-generation sequencing technologies has opened new horizons for a better understanding of the molecular basis of cholangiocarcinoma, and for the identification and evaluation of potential new treatments tailored to the molecular characteristics of patients’ tumours.2

During this symposium, our faculty will discuss the clinical and genetic heterogeneity in cholangiocarcinoma and their potential relevance to disease management. The evolving role of comprehensive molecular profiling to inform potential therapeutic selection, as well as the key considerations, challenges and opportunities associated with the different technologies used for diagnosis and molecular profiling, will be explored. Finally, our faculty will provide an overview of evolving treatment strategies and describe the targets of molecularly driven therapies under investigation. Interactivity will be encouraged during the live Q&A session.

Meeting agenda

Time (CEST) Presentation Speaker
18:20–18:25 Welcome and introduction Prof Bruno Sangro
18:25–18:35 Cholangiocarcinoma: Not a single disease Dr Harpreet Wasan
18:35–18:45 Cholangiocarcinoma molecular characterisation: Challenges and opportunities Dr Ana Vivancos
18:45–19:00 Cholangiocarcinoma clinical research: What’s new? Dr Joachim Mertens
19:00–19:20 Live Q&A, summary and meeting close All

1. Banales JM, et al. Nat Rev Gastroenterol Hepatol. 2020; doi: 10.1038/s41575-020-0310-z;
2. Simile MM, et al. Medicina (Kaunas). 2019;55:42; doi:10.3390/medicina55020042.

A virtual educational event organised and sponsored by Incyte Biosciences International

Date of preparation: July 2020


© 2020, Incyte Biosciences International Sàrl. All rights reserved.